Month: May 2022

Schlieren/Switzerland, 30 May 2022The news release can be downloaded from the following link:AttachmentRelease

VANCOUVER, British Columbia, May 28, 2022 (GLOBE NEWSWIRE) — Blender Bites Ltd. (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL40, WKN: A3DWAM), a Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is pleased to announce that the world’s leading club store chain (the “club chain”) has reordered club size packs of its award winning Power Berry & Green Detox flavour superfood smoothie pucks for the club chain’s Eastern Region Canadian locations. The reorder is for 40,000 units of the product which will be delivered to 42 Eastern Region club store locations in June, including Ontario, Quebec and Canada’s Maritime provinces. The reorder by the club chain’s largest Canadian Region illustrates sustained customer satisfaction...

Maha Energy AB (publ) (“Maha” or the “Company”) is pleased to announce that drilling of the Tie-5 horizontal production well is now complete. TD of the 6-1/8” horizontal hole was reached on 3 May and a 4-1/2” completion liner has now been run. The length of the horizontal leg was reduced due to deteriorating hole conditions. A total of 240 m. of net Agua Grande (AG) sand has been logged using measurement while drilling tools and the horizontal section will now be stimulated and cleaned up before being placed on production. Drilling of the Tie-5 horizontal production reached a measured depth of 2,548 m on 3 May, 2022. A total of 240 m of net AG sand has been drilled and a 4-1/2” pre-perforated production liner has now been run in the hole. The exposed length of sand in Tie-5 should be compared with the 14 m. of net sand penetrated in Tie-4....

FRO – Private acquisitions of Euronav shares in exchange for Frontline shares completed Frontline Ltd. (“Frontline” or the “Company”) (NYSE: FRO – OSE: FRO) announces that it has agreed to acquire a total of 5,955,705 shares in Euronav N.V. (NYSE: EURN & Euronext: EURN) (“Euronav”) representing 2.95% of the outstanding shares in privately negotiated share exchange transactions with certain shareholders of Euronav N.V. where such shareholders of Euronav N.V. receive consideration shares in Frontline. Frontline will issue a total of 8,337,986 new shares as a result of these transactions, equivalent to an exchange ratio of 1.4. Frontline will be entitled to the declared USD 0,06 dividend to be paid by Euronav on the acquired shares on 8 June 2022. Settlement is expected to take place on or about 1 June 2022 by delivery of...

VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN – “Medallion” or the “Company”) is pleased to announce that shareholders have approved all resolutions put forth at the Annual General and Special Meeting of Shareholders (the “Shareholders’ Meeting”) held in Vancouver, BC, on May 27, 2022. In the annual meeting, 34.86% of the eligible shares were represented and all motions put forward by the Company were passed. The number of directors of the Company was fixed at six and Mark Saxon, Rod McKeen, David Shaw, Andrew Morden, Gabriel Alonso-Mendoza and Kurt Forrester were elected as directors of the Company to hold office until the next annual general meeting.  Davidson LLP was re-appointed as auditors of the company and the board is authorized to fix the...

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1Sustained clinical benefit from Kymriah treatment demonstrated – of patients who achieved a complete response, 85% were still in response at 12 months1Kymriah can be administered in the outpatient setting, offering increased flexibility and potentially reducing the burden of therapy for patients and their care teams1,2Kymriah is now FDA approved in three indications and remains the only CAR-T cell therapy approved in both adult and pediatric settings1Basel, May 28, 2022 — Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah® (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory (r/r)...

VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) — Baden Resources Inc. (“Baden” or the “Company”) (CSE:”BDN”) completed exploration in late 2021 on the Midway mining claims property located in southeastern BC, held under option with the claims owner. Baden has completed its firm commitments under the subject option agreement, which included analysis of samples obtained, and has now concluded that the results do not warrant any further expenditure. Baden accordingly will not be proceeding any further with the Midway property and the option and has terminated the option agreement with the owner. The Company is a mineral exploration company focused on the acquisition, exploration and development of mineral properties in Canada and the USA. On Behalf of the Company Howard Milne, Chief Executive Officer For further information,...